Ex-Execs Blame FDA Rules In Off-Label Fraud Trial
Former executives of Johnson & Johnson subsidiary Acclarent Inc. told a Massachusetts federal jury Tuesday that the real impetus for their trial on fraud charges is a government desire to crack...To view the full article, register now.
Already a subscriber? Click here to view full article